The Use of the Propeller Health Platform to Improve Inhaled Corticosteroid (ICS) Use Among Adults With Uncontrolled Persistent Asthma
NCT03860519 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2020-04-03
Summary
This is a behavioral randomized controlled trial of adults with uncontrolled persistent asthma that tests if the Propeller Health sensor, mobile application, and dashboard can improve adherence to ICS.
Conditions
Interventions
- BEHAVIORAL
-
Electronic Medication Monitors on ICS and SABA - Active Mode
The patients in the intervention group will have sensors that are "active", so that these patients receive reminders about when to use their inhalers medications.
- BEHAVIORAL
-
Electronic Medication Monitors on ICS and SABA - Silent Mode
The patients in the control group will have sensors that are "silent", so that these patients do not receive reminders about when to use their inhalers medications.
- BEHAVIORAL
-
Asthma App Tracking of ICS/SABA Usage - Active Mode
Patients in the intervention group will have access to their medication usage information (as collected by their sensors) via their Propeller Health applications.
- BEHAVIORAL
-
Asthma App Tracking of ICS/SABA Usage - Silent Mode
Patients in the control group will not have access to their medication usage information (as collected by their sensors) via their Propeller Health applications.
- BEHAVIORAL
-
NorthShore Connect Real Time ICS and SABA Usage Feedback - Yes
Patients in the intervention will receive feedback from the Research Nurse about their medication use and asthma control status.
- BEHAVIORAL
-
NorthShore Connect Real Time ICS and SABA Usage Feedback - No
Patients in the intervention will not receive feedback from the Research Nurse about their medication use and asthma control status.
- BEHAVIORAL
-
Asthma Nurse Monthly Phone Calls for ICS/SABA Usage Feedback - Yes
Patients in the intervention group will receive monthly calls from the Research Nurse to obtain feedback information about the Propeller Health Platform.
- BEHAVIORAL
-
Asthma Nurse Monthly Phone Calls for ICS/SABA Usage Feedback - No
Patients in the control group will not receive monthly calls from the Research Nurse to obtain feedback information about the Propeller Health Platform.
Sponsors & Collaborators
-
Endeavor Health
lead OTHER
Principal Investigators
-
Giselle Mosnaim, MD · Endeavor Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-03-07
- Primary Completion
- 2019-07-01
- Completion
- 2019-08-01
Countries
- United States
Study Locations
More Related Trials
-
Pilot Study of a Mobile Asthma Adherence Intervention
NCT02413528 ·Status: TERMINATED ·Phase: NA
-
Feasibility Trial of a Mobile Adherence Tool for Adolescents With Asthma
NCT02426801 ·Status: COMPLETED ·Phase: NA
-
Monitoring Adherence Using Mobile Technology
NCT02617420 ·Status: COMPLETED
-
An Asthma Mobile Intervention to Promote Patient-Reported Outcomes in Primary Care
NCT03847142 ·Status: COMPLETED ·Phase: NA
-
A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma
NCT04677959 ·Status: COMPLETED ·Phase: PHASE4
-
Feasibility of a Smartphone Application for Asthma Self-management
NCT05572177 ·Status: RECRUITING ·Phase: NA
-
Inhaler Adherence in Severe Unstable Asthma
NCT02307669 ·Status: UNKNOWN ·Phase: NA
-
Video-based Teach-to-goal Intervention on Inhaler Technique on Jordanian Adults With Asthma and COPD
NCT05664347 ·Status: COMPLETED ·Phase: NA
-
Intervention to Improve Inhalative Adherence
NCT02386722 ·Status: COMPLETED ·Phase: NA
-
Study of Salmeterol (SN408D) for Adult Asthma
NCT00950794 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma
NCT02301975 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics
NCT02496715 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.
NCT00603278 ·Status: COMPLETED ·Phase: PHASE2
-
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma
NCT00452348 ·Status: COMPLETED ·Phase: PHASE4
-
A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma
NCT03890666 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.
NCT00603382 ·Status: COMPLETED ·Phase: PHASE2
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913 ·Status: RECRUITING ·Phase: PHASE4
-
Improving Asthma Treatment Using Inhaler Technology
NCT02977078 ·Status: UNKNOWN ·Phase: NA
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.
NCT00603746 ·Status: COMPLETED ·Phase: PHASE2
-
Technology- Assisted Stepped Care Intervention Study
NCT03733457 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)
NCT01302587 ·Status: COMPLETED
-
Prospective evAluatIon foR Inhalation Devices Study
NCT01800994 ·Status: COMPLETED
-
A Comparative Study To Determine If Motivating Asthma Education (Compliance Enhancement) Has An Effect On Asthma Control
NCT00351143 ·Status: COMPLETED ·Phase: PHASE4
-
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma
NCT00452699 ·Status: COMPLETED ·Phase: PHASE4
-
Dose-Response of Salmeterol in Children
NCT01907334 ·Status: COMPLETED ·Phase: PHASE4